- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02699814
H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation (H3)
The goal of this project is to develop and pilot test a community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems that is replicable, effective, and sustainable. Project procedures include child mental health screening, on-site brief mental health interventions, referral to specialty mental health, use of co-located child psychiatrist, detection of need for primary care in specialty mental health program. Subjects will be enrolled for 1 year, with interviews at baseline and 3, 6 and 12 months.
Dr. Bonnie Zima at UCLA has been contracted by the project funder to design and implement the evaluation of the project, which includes developing data collection procedures, training staff on implementation of data collection workflow, coordinating with sites to ensure evaluation design and IRB protocols are followed, and coordinating with both study sites to verify data reliability.
Some potential anticipated risks include being uncomfortable answering questions associated with the measures used in the study, and although unlikely, someone may access participant information that is confidential. Some benefits include helping to find ways to improve how to deliver mental health care for children served in publicly-funded primary care and mental health clinics.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
UCLA is in charge of the evaluation of the H3 project, including evaluation design and overseeing data collection by project sites. UCLA will receive data collected by each site and perform the analysis of the data for the sites to be shared with the Illinois Children's Healthcare Foundation and clinic sites. This study will evaluate an existing intervention, meaning that participation in the evaluation is not required in order to receive H3 services.
The information below is included in the evaluation design document attached in 10.1, 1.0:
The overarching goal of the Healthy Minds, Healthy Children, Healthy Chicago Initiative (H3) is to develop a community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems that is replicable, effective, and sustainable.
The final study design is a longitudinal cohort study of 400 children ages 0-17 years and their families served at the two intervention clinic sites (n=200/site) The study time points are baseline, 3-, 6-, and 12-months.
The data sources are parent and youth report, and clinic administrative data when feasible for the programs to transfer these data following IRB-approved procedures. The unit of analysis is the child. The main proximal (or short term) clinical outcomes are related to the H3 intervention care processes (e.g., brief mental health interventions, referral to specialty mental health care, co-located child psychiatrist). The time period will likely vary by child depending on clinical need, but it is anticipated that most of these care processes will be provided during the early phase when the child and parent is introduced to the new care model. The main distal outcomes (or more long-term) are clinical improvement (e.g., child symptom reduction, improved functioning) and some correspond to the care process delivered (e.g., if parent receives parent training, improvement parenting skills are assessed). The time points for tracking clinical improvement are 3, 6 and 12 months after the baseline interview that is done when the parent and child are enrolled in the evaluation. The independent variables (or factors that may influence care processes and clinical outcomes) are child sociodemographic characteristics (e.g. age, sex, race/ethnicity), psychosocial complexity, and primary caregiver characteristics that the clinic team or Community Advisory Board deemed relevant (e.g., parenting stress, probable depression). Embedded within the description of a child's psychosocial complexity are indicators of social determinants (e.g. exposure to trauma) that may adversely impact a child's development and well-being.
Findings from this evaluation will provide data on the acceptability and feasibility of the H3 care models, as well as early indicators of whether these care models are promising.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60621
- Miles Square Health Center, Englewood
-
Chicago, Illinois, United States, 60622
- Erie Family Health Center, West Town
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- between the ages of 0.0-16.99 years
- speaks Spanish or English
- screens positive for a developmental delay or mental health problem
- referral to the H3 care program by a pediatrician based on clinical judgment
- no prior history of receiving any H3 services in the past year
Exclusion Criteria (based on the child's characteristics):
- 17 years old (to avoid reconsent at 12 month follow-up)
- has previously had H3 services in the past year
- can not speak English or Spanish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: H3 Parent/Child Dyads
A child is eligible for the H3 partnered evaluation if he or she is: 1) between the ages of 0.0-16.99
years; 2) speaks Spanish or English; 3) screens positive for a developmental delay or mental health problem.
For children in the intervention groups, the additional eligibility criteria are: 1) referral to the H3 care program by a pediatrician based on clinical judgment; and 2) no prior history of receiving any H3 services in the past year.
|
A community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
H3 intervention care processes
Time Frame: 12 months
|
tracking administration (yes/no) of "brief mental health interventions", "referral to specialty mental health care", "use of co-located child psychiatrist", "detected need for primary care"
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mental health functioning
Time Frame: Baseline, 3, 6 and 12 months
|
PHQ9
|
Baseline, 3, 6 and 12 months
|
Child development
Time Frame: 12 monthsBaseline, 3, 6 and 12 months
|
Pediatric Symptom Checklist
|
12 monthsBaseline, 3, 6 and 12 months
|
Child functioning
Time Frame: Baseline, 3, 6 and 12 months
|
Columbia Impairment Scale
|
Baseline, 3, 6 and 12 months
|
Response to trauma and resilience
Time Frame: Baseline, 3, 6 and 12 months
|
Traumatic Events Screening Inventory
|
Baseline, 3, 6 and 12 months
|
Care process delivered
Time Frame: Baseline, 3, 6 and 12 months
|
Questionnaire administered at baseline, 3, 6, and 12 months asking parent and child about any care processes that he/she received.
|
Baseline, 3, 6 and 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Bonnie Zima, MD, MPH, University of California, Los Angeles
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB#15-000757
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Disorder
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
University of WarwickKing's College London; KU Leuven; University Hospital, Montpellier; Erasmus Medical... and other collaboratorsUnknownMental Health Disorder | Mental Health ImpairmentIreland, United Kingdom, Netherlands, Germany, Belgium, Croatia, France, Italy
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
University of HaifaCompletedMental Health DisordersIsrael
-
Laureate Institute for Brain Research, Inc.Enrolling by invitationMental Health Disorder | Mental Health Issue | Assessment, SelfUnited States
-
Boston CollegeUniversity of Georgia; Innovations for Poverty Action; Caritas Freetown; German...CompletedMental Health Disorder | Mental Health Impairment | Psychosocial ProblemSierra Leone
-
ViomeRecruitingDepression | Anxiety Disorders | Anxiety | Mental Health Disorder | Anxiety Depression | Anxiety State | Mental Health | Depression, Anxiety | Mental Health IssueUnited States
Clinical Trials on H3 Services
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers | Influenza ImmunisationUnited States
-
DT MedTech, LLCRecruitingOsteoarthritis Ankle | Post-Traumatic Osteoarthritis of Ankle | Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)United States
-
St. Jude Children's Research HospitalRecruitingGlioblastoma | Central Nervous System Neoplasms | High Grade Glioma | Ependymoma | Medulloblastoma | Diffuse Midline Glioma, H3 K27M-Mutant | Atypical Teratoid/Rhabdoid TumorUnited States
-
Beijing Tiantan HospitalRecruiting
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingPancreas Cancer | Relapse | Resistant CancerUnited States
-
University of WashingtonUniversity of Nairobi; Kenya Ministry of HealthCompleted
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaChina
-
San Francisco Department of Public HealthCompleted
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Tianjin Medical University Cancer Institute and Hospital; Shandong Cancer Hospital...RecruitingB7-H3-positive Relapsed/ Refractory NeuroblastomaChina